The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Tuesday:** Canada's Valeant Pharmaceuticals International Inc said it had partnered with activist investor Bill Ackman in an unsolicited $47 billion bid to purchase Botox maker Allergan Inc in a move to eventually become one of the world's five biggest drug companies. Valeant said it had lined up $15.5 billion in debt financing from Barclays and RBC Capital Markets to fund its proposed
Allergan, Inc. is a multi-specialty health care Company focused on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products. Shares of AGN traded higher by 15.25% or $21.65/share to $163.65. In the past year, the shares have traded as low as $81.33 and as high as $142.00. On average, 3082310 shares of AGN exchange hands on a given day and today's volume is recorded at 32391432.
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX traded higher by 7.46% or $9.4/share to $135.41. In the past year, the shares have traded as low as $71.99 and as high as $153.10. On average, 1992590 shares of VRX exchange hands on a given day and today's volume is recorded at 17981784.
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX traded higher by 7.65% or $10.62/share to $149.38. In the past year, the shares have traded as low as $72.59 and as high as $170.45. On average, 372348 shares of VRX.TO exchange hands on a given day and today's volume is recorded at 1128864.
Source
